Delivery Hero Shares Jump After Prosus Agrees to Sell Stake for $395 Million
By Najat Kantouar
Shares in Delivery Hero climbed after Prosus agreed to sell part of its stake in the company to Aspex Management for around 335 million euros ($394.9 million), marking the latest step in reducing its shareholding in the German delivery company.
The move comes weeks after it sold around 4.5% of its stake in Delivery Hero to U.S. tech company Uber, as part of remedies tied to its acquisition of Just Eat Takeaway.
In August, the European Commission approved Prosus's acquisition of Just Eat Takeaway.com, subject to commitments requiring the investor to significantly reduce its shareholding in Delivery Hero.
In early afternoon European trading, shares were up 10.2% at 22.02 euros. Year to date, shares have fallen 3.1%.
Hong Kong based investment firm Aspex Management is Delivery Hero's second-largest shareholder, holding a 9.23% stake as of Dec. 30, the German company said. Prosus remains the largest shareholder with a 21.83% stake as of April 21, after its stake sale to Uber, it said.
The deal follows Aspex's criticism of Delivery Hero's management in March, when the investor advocated for a change in the management team to address the company's challenges. Aspex previously raised concerns about the company's strategy of expansion into dozens of markets and noted its struggle to boost profitability and generate cash flow.
In response, Delivery Hero said it continues to work diligently to improve profitability and further strengthen operational performance.
Prosus, an Amsterdam-listed technology investor, said Monday that it has agreed to sell around 15.2 million ordinary shares in Delivery Hero to Aspex, representing roughly 5% of Delivery Hero's issued share capital.
The agreed price of 22 euros a share is a roughly 10% premium to Delivery Hero's closing share price and an around 22% premium to the stock's 30-day volume-weighted average price as of Friday, it said.
Delivery Hero declined to comment on Monday's announcement, while Aspex didn't immediately respond to a request for comment .
Write to Najat Kantouar at najat.kantouar@wsj.com
(END) Dow Jones Newswires
May 11, 2026 07:27 ET (11:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
